L-2-hydroxyglutaric aciduria: clinical, neuroimaging, and neuropathological findings

Arch Neurol. 2005 Apr;62(4):666-70. doi: 10.1001/archneur.62.4.666.

Abstract

Background: l-2-Hydroxyglutaric aciduria is a rare, infantile-onset, autosomal recessive organic aciduria affecting exclusively the central nervous system. To our knowledge, only 1 complete report of the neuropathological findings in an adult has been published.

Objective: To present the clinical, neuroimaging, and neuropathological findings of l-2-hydroxyglutaric aciduria.

Design: Case report.

Setting: Complexo Hospitalario de Pontevedra, Pontevedra, Spain.

Patient: A 15-year-old boy who had early infantile-onset progressive psychomotor regression, mild choreodystonia affecting the distal part of the upper limbs, pyramidal signs, and epilepsy.

Results: The diagnosis of l-2-hydroxyglutaric aciduria was confirmed by the finding of highly elevated levels of l-2-hydroxyglutaric acid in the serum, urine, and cerebrospinal fluid. The neuroimaging findings showed striking confluent subcortical white matter lesions and minimal basal ganglia (pallidum, thalamic, and putaminal) abnormalities. The patient died of a spontaneous mesenteric thrombosis. The postmortem neuropathological findings showed spongiosis and cystic cavitations in subcortical white matter, with minimal abnormalities of the basal ganglia. The dentate nucleus, a structure usually affected in neuroimaging studies, showed minimal neuronal loss but was surrounded by important spongiosis and microvacuolation with astrocytic proliferation.

Conclusions: This case reaffirms that l-2-hydroxyglutaric aciduria is a spongiform type of leukoencephalopathy with cystic cavitations predominating in the subcortical areas. Although the neuroimaging findings are highly characteristic of the disease, in this patient cerebellar abnormalities were minimal and dentate signal abnormalities were not present.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Atrophy / etiology
  • Atrophy / pathology
  • Atrophy / physiopathology
  • Brain / metabolism
  • Brain / pathology*
  • Brain / physiopathology*
  • Brain Diseases, Metabolic, Inborn / blood*
  • Brain Diseases, Metabolic, Inborn / pathology*
  • Brain Diseases, Metabolic, Inborn / urine
  • Epilepsy / etiology
  • Epilepsy / metabolism
  • Epilepsy / physiopathology
  • Fatal Outcome
  • Folic Acid / therapeutic use
  • Genes, Recessive / genetics
  • Glutarates / blood*
  • Glutarates / cerebrospinal fluid
  • Glutarates / urine*
  • Humans
  • Intellectual Disability / genetics
  • Intellectual Disability / metabolism
  • Intellectual Disability / pathology
  • Magnetic Resonance Imaging
  • Male
  • Mesenteric Vascular Occlusion / etiology
  • Mesenteric Vascular Occlusion / pathology
  • Mesenteric Vascular Occlusion / physiopathology
  • Mesenteric Veins / pathology
  • Mesenteric Veins / physiopathology
  • Nerve Fibers, Myelinated / metabolism
  • Nerve Fibers, Myelinated / pathology
  • Spain

Substances

  • Glutarates
  • alpha-hydroxyglutarate
  • Folic Acid